Dr Reddys Laboratories Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|
| Revenue | 4,982.80 | 8,207.80 | 5,977.30 |
| Operating Expense | 4,138.30 | 3,972.50 | 4,119.90 |
| Net Profit | 387.30 | 2,961.20 | 1,200.70 |
| Net Profit Margin | 7.77 | 36.08 | 20.09 |
| Earning Per Share | 4.65 | 35.59 | 14.41 |
| EBIDTA | 793.20 | 4,201.90 | 1,860.60 |
| Effective Tax Rate | 9.20 | 22.23 | 19.61 |
| Particulars | Sep 2025 |
|---|---|
| Revenue | 4982.80 |
| Operating Expense | 4138.30 |
| Net Profit | 387.30 |
| Net Profit Margin | 7.77 |
| Earning Per Share | 4.65 |
| EBIDTA | 793.20 |
| Effective Tax Rate | 9.20 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 23,115.40 | 19,483.80 | 16,962.50 |
| Operating Expenses Annual | 15,733.60 | 13,557.40 | 12,747.70 |
| Operating Profit Annual | 8,385.20 | 6,788.70 | 4,806.10 |
| Interest Annual | 109.90 | 21.80 | 16.90 |
| Depreciation | 818.40 | 758.10 | 698.10 |
| Net Profit Annual | 5,349.40 | 4,342 | 2,612.80 |
| Tax Annual | 1,886.50 | 1,449.30 | 1,253.20 |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 23,115.40 |
| Operating Expenses Annual | 15,733.60 |
| Operating Profit Annual | 8,385.20 |
| Interest Annual | 109.90 |
| Depreciation | 818.40 |
| Net Profit Annual | 5,349.40 |
| Tax Annual | 1,886.50 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 201.40 | 112.30 | 1,159.50 |
| Cash Flow from Operations | 4,225 | 3,449.70 | 5,052.90 |
| Cash Flow from Investing | -5,697.40 | -3,428.70 | -3,403.20 |
| Cash Flow from Financing | 1,590.70 | 68.10 | -2,696.90 |
| Cash Flow at the End | 319.70 | 201.40 | 112.30 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 201.40 |
| Cash Flow from Operations | 4,225 |
| Cash Flow from Investing | -5,697.40 |
| Cash Flow from Financing | 1,590.70 |
| Cash Flow at the End | 319.70 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | 36.28 | 34.84 | 28.33 |
| PBIT Margin (%) | 31.78 | 29.84 | 22.89 |
| PBT Margin (%) | 31.49 | 28.47 | 21.54 |
| Net PROFIT Margin (%) | 23.14 | 22.29 | 15.40 |
| Return On Networth / Equity (%) | 20.15 | 19.42 | 13.46 |
| Return On Networth /Employed (%) | 25.47 | 25.40 | 18.82 |
| Return On Assets (%) | 18.51 | 18.94 | 12.63 |
| Total Debt / Equity (X) | 0.08 | 0.02 | 0.06 |
| Asset Turnover Ratio (%) | 0.80 | 0.85 | 0.82 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | 36.28 |
| PBIT Margin (%) | 31.78 |
| PBT Margin (%) | 31.49 |
| Net PROFIT Margin (%) | 23.14 |
| Return On Networth / Equity (%) | 20.15 |
| Return On Networth /Employed (%) | 25.47 |
| Return On Assets (%) | 18.51 |
| Total Debt / Equity (X) | 0.08 |
| Asset Turnover Ratio (%) | 0.80 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 8,272.80 | 7,628.20 | 7,220.60 |
| Total Current Assets Annual | 16,503 | 17,815.90 | 13,788.30 |
| Non Current Assets Annual | 21,787.90 | 12,543.40 | 11,586.50 |
| Total Shareholders Funds Annual | 28,856.60 | 24,240.80 | 20,474.20 |
| Total Assets Annual | 38,290.90 | 30,359.30 | 25,374.80 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 8,272.80 |
| Total Current Assets Annual | 16,503 |
| Non Current Assets Annual | 21,787.90 |
| Total Shareholders Funds Annual | 28,856.60 |
| Total Assets Annual | 38,290.90 |
EPS (INR)
Expected
16.13
Reported
16.18
Surprise
0.31%
Jun 2025
EPS beaten by 0.31%
Mar 2025
EPS beaten by 0.35%
Dec 2024
EPS beaten by 0.10%
